-
CUE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Cue Biopharma (CUE)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 32.57 mm | 32.57 mm | 32.57 mm | 32.57 mm | 32.57 mm | 32.57 mm |
Cash burn (monthly) | (no burn) | 1.71 mm | 2.94 mm | 3.61 mm | 2.51 mm | 2.93 mm |
Cash used (since last report) | n/a | 4.81 mm | 8.27 mm | 10.16 mm | 7.07 mm | 8.24 mm |
Cash remaining | n/a | 27.77 mm | 24.30 mm | 22.41 mm | 25.51 mm | 24.34 mm |
Runway (months of cash) | n/a | 16.3 | 8.3 | 6.2 | 10.2 | 8.3 |
13F holders | Current |
---|---|
Total holders | 74 |
Opened positions | 24 |
Closed positions | 20 |
Increased positions | 14 |
Reduced positions | 18 |
13F shares | Current |
---|---|
Total value | 16.65 bn |
Total shares | 13.80 mm |
Total puts | 11.10 k |
Total calls | 56.10 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Bleichroeder | 2.86 mm | $3.55 bn |
Slate Path Capital | 2.40 mm | $2.98 bn |
Vanguard | 2.03 mm | $2.52 bn |
BLK BlackRock | 756.74 k | $938.35 mm |
Millennium Management | 493.99 k | $612.54 mm |
Geode Capital Management | 492.46 k | $610.79 mm |
Robertson Stephens Wealth Management | 478.50 k | $593.34 mm |
NTRS Northern Trust | 350.42 k | $434.52 mm |
Good Life Advisors | 325.00 k | $403.00 mm |
Gsa Capital Partners | 277.56 k | $344.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Dec 24 | Daniel R Passeri | Common Stock | Buy | Acquire P | No | No | 1.03 | 30,000 | 30.90 k | 164,578 |
25 Nov 24 | Daniel G. Baker | Stock Option Common Stock | Grant | Acquire A | No | No | 1.06 | 200,000 | 212.00 k | 200,000 |
3 Sep 24 | Lucinda Warren | Stock Option Common Stock | Grant | Acquire A | No | No | 0.66 | 350,000 | 231.00 k | 350,000 |